The FADS1 enzyme has been shown to induce the enrichment of Gram-negative bacteria through a high arachidonic acid microenvironment, activate the conversion of the TLR4/MYD88 pathway to PGE2, and ultimately promote CRC tumorigenesis [53]. Here, MYD88 is linked to colorectal carcinoma.